CN1395963A - Composite medicine for disinfecting and relieving inflammation - Google Patents

Composite medicine for disinfecting and relieving inflammation Download PDF

Info

Publication number
CN1395963A
CN1395963A CN 02138915 CN02138915A CN1395963A CN 1395963 A CN1395963 A CN 1395963A CN 02138915 CN02138915 CN 02138915 CN 02138915 A CN02138915 A CN 02138915A CN 1395963 A CN1395963 A CN 1395963A
Authority
CN
China
Prior art keywords
parts
composition
pharmaceutical composition
nystatin
chlorhexidine acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 02138915
Other languages
Chinese (zh)
Inventor
黄谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 02138915 priority Critical patent/CN1395963A/en
Publication of CN1395963A publication Critical patent/CN1395963A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A disinfecting and anti-inflammatory composite medicine for treating gynopathy is prepared from 7 raw materials including purpleflower Elsthotzia, wild chrysanthemum flower, moronal, chlorhexidine acetate, crudium fruit, etc.. Its advantages are high disinfecting rate up to 97% within 30 min, and deodouring action.

Description

A kind of pharmaceutical composition with bactericidal antiphlogistic effect
Technical field
The present invention relates to pharmaceutical composition, particularly a kind of pharmaceutical composition with bactericidal antiphlogistic effect is applicable to various gynaecopathias and bacillary, mycotic that prevention or treatment are directly or indirectly infected.
Background technology
Along with the progress of social civilization, the quickening of rhythm of life, individual health care is more and more important.Wherein the women is as the carrier of mankind's procreation, and its reproductive health care is particularly crucial.Based on the influence to the women of female pathology characteristic and modern environment factor, its pudendum and genitals health care require more and more higher, and the easiest invasion and attack female vulva of various pathogenic microorganism and genitals.If self health consciousness is not strong, very easily infect and cause a disease, cause various inflammatories and change and multiple gynecological diseases.Therefore keep the female vulva cleaning, keep its normal physiological self-cleaning action, use certain health-care sterilized product particularly important.This for female reproduction health and orthobiosis order maintenance all have positive effect.Chinese patent CN99113318 " a kind of traditional Chinese medical science pill for the treatment of gynaecopathia " discloses a kind of traditional Chinese medical science pill, i.e. phoenix tail ball, and have following deficiency: (1), prescription medicine are more, and preparation technology is complicated, and production cost is higher; (2), phoenix tail ball ball type is sphere or column type reuse bundle drug of topical application ball, and on gauze, reserve the fag end of 6.7cm, cause leaves fag end and gauze: a, the patient can have uncomfortable sensation, b, in the surgery, fag end and gauze are foreign body, stay the focus of infection place, easily cause the disunion or the superinfection that infect; (3), the every pill of phoenix tail ball imitated 10 days, must continuously pill be placed intravaginal in 10 days, easily caused patient's discomfort.
Summary of the invention
The object of the invention easily causes patient's discomfort, easily causes infecting that disunion or superinfection and preparation technology are complicated, the higher defective of production cost for what overcome that existing medicament exists, and a kind of pharmaceutical composition with bactericidal antiphlogistic effect is provided, have sterilization, determined curative effect and reach advanced reasonably prescription lastingly.
Medicine of the present invention is a kind of compositions, and the composition of said composition is as follows by weight ratio:
Pale reddish brown fragrant 475-525 part Flos Chrysanthemi Indici 1900-2100 part
Fructus Cnidii 950-1050 part Herba Eupatorii 950-1050 part
Nystatin 1.52-1.92 part (1,000 ten thousand u) chlorhexidine acetate 0.7-0.9 part
0.1 part of semi-synthetic ester fat acid ester 36# 180-220 part of Borneolum Syntheticum
An amount of substrate 180-220 part of essence (U.S. refreshing)
Above-mentioned composition component preferred weight proportioning of the present invention is as follows:
Pale reddish brown fragrant 450-550 part Flos Chrysanthemi Indici 1800-2200 part
Fructus Cnidii 900-1100 part Herba Eupatorii 900-1100 part
Nystatin 1.62-1.82 part (1,000 ten thousand u) chlorhexidine acetate 0.74-0.84 part
0.1 part of semi-synthetic ester fat acid ester 36# 190-210 part of Borneolum Syntheticum
An amount of substrate 190-210 part of essence (U.S. refreshing)
Above-mentioned composition component optimum weight proportioning of the present invention is as follows:
2000 parts of pale reddish brown fragrant 500 parts of Flos Chrysanthemi Indicis
1000 parts of 1000 portions of Herba Eupatoriis of Fructus Cnidii
Nystatin 1.72g (1,000 ten thousand u) 0.8 part of chlorhexidine acetate
200 parts of 0.1 part of semi-synthetic ester fat acid ester 36# of Borneolum Syntheticum
200 parts of an amount of substrate of essence (U.S. refreshing)
This pharmaceutical composition is by pale reddish brown perfume (or spice) (Herba Moslae, HM), Flos Chrysanthemi Indici (FlosChrysanthemi Indici, FCI), Fructus Cnidii (Fructes Cnidii, FC), Herba Eupatorii (HerbaEupatorii, HE) four flavor natural plants medicament extracts and Nystatin (Nystatin), chlorhexidine acetate (Chlorohexidine), Borneolum Syntheticum (Borneolum Syntheticum) etc., and suppository base is formed.Wherein pale reddish brown perfume (or spice) and Flos Chrysanthemi Indici heat-clearing and toxic substances removing, Fructus Cnidii the kidney warming dampness, wind dispelling insecticide, Herba Eupatorii removing dampness by means of aromatics, four medicines share the effect that has repelling foulness with aromatics, detoxifies removing dampness, be the key component of this product exploitation Chinese medicine as main sterilization effect, and Nystatin, chlorhexidine acetate have the clear and definite effect of killing fungus and common pathogen, with natural drug good complementary relationship are arranged.
Aforementioned pharmaceutical compositions can be prepared into various conventional dose according to the practice of pharmacy of routine, for example: suppository, lotion etc.
Medical material is bought by Hubei Province's medical material company.
The preparation method of drug suppository of the present invention:,, get Chinese medicines such as pale reddish brown perfume (or spice), Flos Chrysanthemi Indici, Fructus Cnidii, Herba Eupatorii according to described consumption with aforementioned pharmaceutical compositions, steam distillation extracts, collect the about 5000~6000ml of fraction, separate volatile oil, also available in case of necessity extracted with diethyl ether; Take by weighing substrate 200g,, add nystatin, chlorhexidine acetate, Borneolum Syntheticum, volatile oil and an amount of essence respectively, mix,, solidify the back to suppository and take out, pack stirring suspension notes film, cooling 50~60 ℃ of fusions.
This pharmaceutical composition passes through rational formula, has the bactericidal antiphlogistic effect, sterilization, determined curative effect is lasting: in repeatedly experimentation in recent years, we contrast this pharmaceutical composition and like product through animal and clinical random packet double-blind method, learn the testing identity pharmaceutical composition by statistics and be better than other series products.This pharmaceutical composition is applicable to and prevents directly and the various gynaecopathias and bacillary, the mycotic of indirect infection.Modern pharmacology confirms that also this pharmaceutical composition reaches more than 97% staphylococcus aureus, escherichia coli, white chain pearl coccus sterilizing rate under 15-30 minute situation of effect.
Another advantage of this pharmaceutical composition is unique prescription, gynecological infection many with leucorrhoea grow in quantity, abnormal flavour is arranged, domestic multiple Amino-Cerv at present mostly is symptomatic treatment or to because of handling, and how the abnormal flavour that this type of disease causes is eliminated, then research seldom; The change of the female mental state that this type of disease is caused, do not give enough attention especially, this pharmaceutical composition not only allows user eliminate abnormal flavour but also allows user give out one delicate fragrance all over the body in bactericidal antiphlogistic, no longer includes the misgivings of heart with back user.Demonstrate fully the theory of " people-oriented for science and technology ", treatment of diseases and daily health caring are combined.
[composition] this product is made up of pale reddish brown perfume (or spice), Flos Chrysanthemi Indici, Nystatin, chlorhexidine acetate, Fructus Cnidii, Herba Eupatorii and suppository base.
The cleaning of [scope of application] vaginal mucosa is antibacterial.
After cleaning vagina before [usage and dosage] 1. sleeps every night, include medicine in vagina, each one with the forefinger that is with the colloid fingerstall; 2. when being used for generally cleaning, warm water dissolves an amount of suppository and directly cleans pudendum.
[points for attention] 1. this suppository are medicine for external use, must not be oral; 2. the anemia of pregnant woman is forbidden; 3. anaphylaxis person's forbidding is arranged; 4. must be with aseptic fingerstall during vagina medicinal, prevent germ contamination; 5. this product can be used for general cleaning, only needs warm water to dissolve the back cleaning and gets final product; 6. because of temperature is too high suppository is dissolved or during deliquescing, can after the freezing shaping of refrigerator, exercise again and use.
Deposit at [storage] shady and cool dry place below 35 ℃.
[effect duration] 12 months
The specific embodiment
Embodiment 1
Pharmaceutical composition composition weight proportioning of the present invention is as follows:
1900 parts of pale reddish brown fragrant 475 parts of Flos Chrysanthemi Indicis
950 parts of 950 portions of Herba Eupatoriis of Fructus Cnidii
Nystatin 1.62g (1,000 ten thousand u) 0.7 part of chlorhexidine acetate
180 parts of 0.1 part of semi-synthetic ester fat acid ester 36# of Borneolum Syntheticum
180 parts of an amount of substrate of essence (U.S. refreshing)
The preparation method of drug suppository of the present invention:,, get pale reddish brown perfume (or spice), Flos Chrysanthemi Indici, Fructus Cnidii, Herba Eupatorii Chinese medicine according to described consumption with aforementioned pharmaceutical compositions, steam distillation extracts, collect the about 5000~6000ml of fraction, separate volatile oil, also available in case of necessity extracted with diethyl ether; Take by weighing substrate,, add nystatin, chlorhexidine acetate, Borneolum Syntheticum, volatile oil and an amount of essence respectively, mix,, solidify the back to suppository and take out, pack stirring suspension notes film, cooling 50~60 ℃ of fusions.
Embodiment 2
Pharmaceutical composition composition weight proportioning of the present invention is as follows:
2100 parts of pale reddish brown fragrant 525 parts of Flos Chrysanthemi Indicis
1050 parts of 1050 portions of Herba Eupatoriis of Fructus Cnidii
Nystatin 1.82g (1,000 ten thousand u) 0.9 part of chlorhexidine acetate
220 parts of 0.1 part of semi-synthetic ester fat acid ester 36# of Borneolum Syntheticum
220 parts of an amount of substrate of essence (U.S. refreshing)
The preparation method of drug suppository of the present invention is identical with embodiment 1.
Embodiment 3
Pharmaceutical composition composition weight proportioning of the present invention is as follows:
2000 parts of pale reddish brown fragrant 500 parts of Flos Chrysanthemi Indicis
1000 parts of 1000 portions of Herba Eupatoriis of Fructus Cnidii
Nystatin 1.72g (1,000 ten thousand u) 0.8 part of chlorhexidine acetate
200 parts of 0.1 part of semi-synthetic ester fat acid ester 36# of Borneolum Syntheticum
200 parts of an amount of substrate of essence (U.S. refreshing)
The preparation method of drug suppository of the present invention is identical with embodiment 1.
This drug suppository bactericidal effect sees Table 1
Table 1 bactericidal effect
Project Concentration Action time (min) Sterilizing rate (%)
Golden yellow staphylococcus (ATCC6538) Stock solution ????15 ????≥99.90
Escherichia coli (8099) Stock solution ????20 ????≥99.90
Candida albicans (ATCC10231) Stock solution ????30 ????≥99.90
The preparation method technical maturity of drug suppository of the present invention, wherein the natural drug extraction separation goes out effective volatile oil and nystatin and molten matrix, forms through mixing, notes film, condensation, membrane removal packing, meets the relevant regulations that national drug is produced.This drug suppository has the significant advantage that Chinese medicine and western medicine closes system at the disinfection product scope, effect rapidly, curative effect is lasting, easy to use is its distinguishing feature, its mesostroma is chosen 36 ℃--37 ℃ of semi-synthetic fatty acids that dissolve, make it under the human body normal body temperature, can discharge ingredient, be easy to ensure the quality of products and under room temperature (25 ℃ ± 5 ℃), be solid state, through the sample survey of Hubei Province Center for Disease Control (CDC), this drug suppository is safe and reliable, the anxious poison test of per os, the skin irritation test, eye irritant test, the vaginal irritation test is all negative, do not see the cumulative toxicity reaction, mutagenicity test is also negative.Its stability test meets the relevant regulations of the examination and test of products, does not see that specificity changes.This drug suppository effective component is clear and definite, and content assaying method and has been formulated the technical standard of clear and definite standard for this drug suppository accurately and reliably, and the quality control of product is reliable.

Claims (4)

1, a kind of pharmaceutical composition with bactericidal antiphlogistic effect is characterized in that the composition of said composition is by weight ratio:
Pale reddish brown fragrant 475-525 part Flos Chrysanthemi Indici 1900-2100 part
Fructus Cnidii 950-1050 part Herba Eupatorii 950-1050 part
Nystatin 1.52-1.92 part (1,000 ten thousand u) chlorhexidine acetate 0.7-0.9 part
0.1 part of semi-synthetic ester fat acid ester 36# 180-220 part of Borneolum Syntheticum
An amount of substrate 180-220 part of essence (U.S. refreshing)
2,, it is characterized in that said composition composition preferred weight proportioning is according to the described pharmaceutical composition of claim 1:
Pale reddish brown fragrant 450-550 part Flos Chrysanthemi Indici 1800-2200 part
Fructus Cnidii 900-1100 part Herba Eupatorii 900-1100 part
Nystatin 1.62-1.82 part (1,000 ten thousand u) chlorhexidine acetate 0.74-0.84 part
0.1 part of semi-synthetic ester fat acid ester 36# 190-210 part of Borneolum Syntheticum
An amount of substrate 190-210 part of essence (U.S. refreshing)
3,, it is characterized in that said composition component optimum weight proportioning is according to the described pharmaceutical composition of claim 1:
2000 parts of pale reddish brown fragrant 500 parts of Flos Chrysanthemi Indicis
1000 parts of 1000 portions of Herba Eupatoriis of Fructus Cnidii
0.8 part of Nystatin 1.72g (1,000 ten thousand u) chlorhexidine acetate
200 parts of 0.1 part of semi-synthetic ester fat acid ester 36# of Borneolum Syntheticum
200 parts of an amount of substrate of essence (U.S. refreshing)
4,, it is characterized in that this pharmaceutical composition is that practice of pharmacy is prepared into suppository or lotion according to claim 1,2 or 3 described pharmaceutical compositions.
CN 02138915 2002-08-13 2002-08-13 Composite medicine for disinfecting and relieving inflammation Pending CN1395963A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02138915 CN1395963A (en) 2002-08-13 2002-08-13 Composite medicine for disinfecting and relieving inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02138915 CN1395963A (en) 2002-08-13 2002-08-13 Composite medicine for disinfecting and relieving inflammation

Publications (1)

Publication Number Publication Date
CN1395963A true CN1395963A (en) 2003-02-12

Family

ID=4749788

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02138915 Pending CN1395963A (en) 2002-08-13 2002-08-13 Composite medicine for disinfecting and relieving inflammation

Country Status (1)

Country Link
CN (1) CN1395963A (en)

Similar Documents

Publication Publication Date Title
CN100420432C (en) Gargle and its preparing process
US8765819B2 (en) Composition comprising benzoic acid in combination with organic acid preservatives as active ingredients and the use thereof
CN104224923A (en) Tea tree essential oil antimicrobial gel for treating vaginal disease in gynecology
US20130108599A1 (en) Herbal Vaginal Compositions
US10478463B2 (en) External-use medicament for cleaning and care of the ovaries, vagina, and vulva
CN110384725B (en) A Chinese medicinal composition for regulating oral flora and preparation method of active extract thereof
CN110721095B (en) Herbal oral bacteriostatic spray containing propolis and preparation method thereof
Coppock Bee products as nutraceuticals to nutraceuticals for bees
CN114796300A (en) Preparation method of luffa whole juice freeze-dried powder, luffa whole juice freeze-dried powder and application thereof
CN109288889A (en) A kind of antibacterial gynecological composition, gel and preparation method thereof
CN101797269B (en) Physiological balance liquid for adjusting microecology in vaginas of women
CN111297961A (en) Dong medicine for promoting wound healing
CN108498535A (en) A kind of povidone iodine pharmaceutical composition and its preparation method and application for treating skin and mucosa infection
CN104857413A (en) Traditional Chinese medicine composition removing oral malodor and preparation method therefor
CN100431617C (en) New use of orange essence in sterilizing
Conrick Neem: the ultimate herb
CN108404111A (en) One kind is with kidney bean phytolectin inhibitory anti-virus preparation as main component
CN106237029B (en) A kind of aloe antibiotic gel and preparation method thereof
CN1395963A (en) Composite medicine for disinfecting and relieving inflammation
CN109464655B (en) External capsule preparation for preventing and treating vaginitis
CN112826849A (en) Compound traditional Chinese medicine with broad-spectrum antibacterial, anti-inflammatory and antiviral effects and preparation method thereof
CN1268355C (en) Traditional Chinese medicine for treating cow endo metritis
CN1107506C (en) Medicine for treating tinea
CN1462584A (en) Externally-used disinfector
CN104208194B (en) Traditional Chinese medicine composition for treating bovine endometritis, preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication